|
|
|
This is the preliminary program for the 2007 Joint Statistical
Meetings in Salt Lake City, Utah.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2007 Program page |
= Applied Session,
= Theme Session,
= Presenter
521
|
Thu, 8/2/07, 10:30 AM - 12:20 PM | CC-355 F |
| Some Practical Considerations for Statisticians Designing Clinical Trials - Invited - Papers | ||
|
Statisticians in the Pharmaceutical Industry, ENAR, Biometrics Section, Biopharmaceutical Section |
||
| Organizer(s): Sara H. Hughes, GlaxoSmithKline, John W. Stevens, AstraZeneca | ||
| Chair(s): Sue-Jane Wang, Food and Drug Administration | ||
| 10:35 AM |
Statistical Considerations in Planning Drug Clinical Trials —  H.M. James Hung, Food and Drug Administration
|
|
| 11:00 AM |
Performance of Multiple Testing Procedures To Compare Three Doses of a Test Drug and Placebo — Lan Kong, University of Pittsburgh; Gary Koch, The University of North Carolina at Chapel Hill; Thomas Liu, Amgen Inc.; Huei Wang, Amgen Inc.
|
|
| 11:25 AM |
Choice of the Primary Analysis in Longitudinal Clinical Trials — Craig Mallinckrodt, Eli Lilly and Company
|
|
| 11:50 AM |
Bioequivalence and the Pharmaceutical Industry — Scott Patterson, GlaxoSmithKline; Byron Jones, Pfizer Inc.
|
|
| 12:15 PM | Floor Discussion | |
|
JSM 2007
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |